GlassScriptPhysician profile
Lindsey Fix
NPI 1972913259
$5,174.36
in general payments reported to CMS, 2019-2025
21 companies · $1,328 in 2025
The $1,328 reported for 2025 was more than what 80% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $288 · 2021: $469 · 2022: $1,084 · 2023: $402 · 2024: $1,221 · 2025: $1,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,771 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,771.09 |
| Education | $178.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,181.76 | 2019-2025 | Tremfya |
| Abbvie INC. | $802.29 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $642.58 | 2022-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $538.11 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Genzyme Corporation | $358.04 | 2020-2025 | |
| Janssen Scientific Affairs, LLC | $250.71 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $241.06 | 2023-2025 | Sotyktu |
| Ucb, INC. | $238.91 | 2021-2025 | Bimzelx |
| Amgen INC. | $211.93 | 2020-2025 | Otezla, Otezla |
| Genentech USA, INC. | $135.60 | 2019-2025 | Xolair |
| Incyte Corporation | $113.90 | 2023-2024 | Opzelura |
| Novartis Pharmaceuticals Corporation | $112.38 | 2021-2025 | |
| Pfizer INC. | $98.52 | 2022 | |
| Sanofi-Aventis U.S. LLC | $79.99 | 2025 | |
| Sun Pharmaceutical Industries INC. | $36.71 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocon Biologics INC | $36.04 | 2025 | Hulio, Yesintek |
| Helsinn Therapeutics (U.S.), INC. | $28.43 | 2022 | |
| Dusa Pharmaceuticals, INC. | $19.17 | 2019 | |
| Strata Skin Sciences, INC. | $17.92 | 2024 | Xtrac |
| Kyowa Kirin, INC. | $16.48 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Fix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.